Company Filing History:
4 out of 200 
Years Active: 2019
Title: The Innovative Contributions of Rupert Brooks
Introduction
Rupert Brooks is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of radiation therapy, holding three patents that showcase his innovative approach to improving treatment methods. His work focuses on enhancing the precision and effectiveness of radiation therapy through advanced tracking systems.
Latest Patents
One of Rupert Brooks' latest patents is titled "System and method for target tracking using a quality indicator during radiation therapy." This patent describes a method that determines a localization result indicating the location of a target in a series of images acquired during radiation therapy. The method also involves assessing a quality indicator for each localization result and extracting features from these results to improve accuracy.
Another significant patent is "Therapy control using motion prediction based on cyclic motion model." This invention outlines an image-guided therapy delivery system that includes a therapy generator and an imaging input. The system is designed to automatically predict the target locus and generate an updated therapy protocol, ensuring that the therapy beam aligns with the moving target during treatment.
Career Highlights
Rupert Brooks is currently employed at Elekta, Inc., a company renowned for its innovative solutions in radiation therapy. His work at Elekta has allowed him to apply his expertise in developing advanced therapeutic technologies that enhance patient care and treatment outcomes.
Collaborations
Throughout his career, Rupert has collaborated with talented professionals, including Leila Pishdad and Michel Moreau. These collaborations have contributed to the development of cutting-edge technologies in the field of radiation therapy.
Conclusion
Rupert Brooks is a distinguished inventor whose work has significantly impacted the field of radiation therapy. His innovative patents and contributions to Elekta, Inc. demonstrate his commitment to improving treatment methods for patients. His ongoing efforts in this field continue to pave the way for advancements in medical technology.